HOME >> MEDICINE >> NEWS
Novel Biological Interaction Found To Explain Blood Vessel Growth To Tumors

DURHAM, N.C. -- Duke University Medical Center researchers believe they have answered one of cancer's central enigmas: why some blood vessels are able to grow to, and feed, tumors, while other vessels are not. In the March 16 issue of the Proceedings of the National Academy of Science, the scientists report the blood protein angiostatin, which is known to stop the growth of new blood vessels to tumors, works by depleting the chemical energy that blood vessel cells need to grow.

To do this, angiostatin latches on to and inhibits ATPsynthase, an enzyme that provides chemical energy for the cell. Without that energy, blood vessels cannot grow to the site of a tumor, and without the nutrient supply in blood, tumors cannot grow larger than a pinhead.

Conversely, when unchecked by angiostatin, ATPsynthase provides a generator of sorts to blood vessels so that they can survive in the atmosphere of cell death caused by cancer. Cancer researchers have long wondered how these vessels stay vigorous enough to continue to grow to and feed tumors.

Lead scientists Dr. Sal Pizzo and Tammy Moser said the discovery is "startling" because the ATPsynthase enzyme has never before been found on the surface of endothelial cells, which are the cells that line blood vessels.

In fact, ATPsynthase has not been known to exist outside of a cell body. It has only been found within a mitochondria, a sac-like structure which acts as a cell's chemical powerhouse.

"It was surprising to see ATPsynthase on blood vessel cells because it was never expected there," said Pizzo in an interview. "But it makes perfect biological sense, and it's terribly exciting."

The finding offers both theoretical as well as practical implications, Pizzo said. It offers a novel insight into the body's use of ATPsynthase as "power packs" in situations where energy is depleted. And it suggests a new route to developing drugs that block angiostatin.

"Instead of using the whole angiostatin p
'"/>

Contact: Renee Twombly
Twomb001@mc.duke.edu
919-684-4148
Duke University Medical Center
16-Mar-1999


Page: 1 2 3 4

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
9. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
10. Novel findings about neovessel formation
11. Novel MRI technique provides clear images of blood flow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... LANCASTER, Pa. (PRWEB) , ... November 08, 2019 ... ... institution for the health care field, is pleased to announce that after the ... stay above the 90th percentile with a 94.73% average pass rate. The College’s ...
(Date:11/7/2019)... HAUPPAUGE, N.Y. (PRWEB) , ... November 06, 2019 , ... ... in fighting the flu is to get the flu shot. Since the flu season ... Flu Vaccination Clinic in early Fall, where their employees can simply sign-up and get ...
(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... , ... select southern markets. The product line includes a 4 and a 7 hour formulations. ... transmit diseases, such as Zika, West Nile Virus and Encephalitis, without exposing them to ...
(Date:11/7/2019)... , ... November 07, 2019 , ... ... co-founder of Ignite and Expand got together on the Shamangelic Healing Podcast ... of downloads skyrocketed. With a trending focus on learning ways to use bio-hacking ...
(Date:11/6/2019)... , ... November 06, 2019 , ... ... and the University of Kentucky Research Foundation (UKRF) today announced they have entered ... will give hemp-derived product companies access to the broad resources of each organization ...
Breaking Medicine News(10 mins):
(Date:11/5/2019)... MONTCLAIR, N.J. (PRWEB) , ... November 05, 2019 ... ... San Antonio, 555 South Alamo Street in Texas will be a timely program ... instruction in the management of chronic pain. , The Texas Medical Board requires ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... Nov. 13-14: How to Build a Sponsor Risk Management Program, Friday, Nov. ... Wednesday-Friday, Nov. 13-15, 2019 • Philadelphia, PA , https://www.fdanews.com/cwiche6gcp , ...
(Date:11/4/2019)... ... ... E-Z-C Pak Creator Dr. Sarath Malepati reeled in famed entrepreneur ... Shark Tank on ABC. EZC Pak is a physician formulated immune support pack composed ... use in colds and flu. , Dr. Malepati negotiated a $125,000 investment for a ...
Breaking Medicine Technology:
Cached News: